• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study. Letter.

作者信息

Peng Chih-Kai, Sung Wen-Wei, Chen Sung-Lang

机构信息

Department of Urology, Chung Shan Medical University Hospital, Taichung, Taiwan.

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.

出版信息

J Urol. 2023 May;209(5):845-846. doi: 10.1097/JU.0000000000003407. Epub 2023 Mar 9.

DOI:10.1097/JU.0000000000003407
PMID:36893470
Abstract
摘要

相似文献

1
Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study. Letter.新辅助膀胱内丝裂霉素-C疗法在非肌层浸润性膀胱癌患者经尿道膀胱肿瘤切除术前即刻的临床疗效：一项前瞻性、随机II期研究的初步结果。信函
J Urol. 2023 May;209(5):845-846. doi: 10.1097/JU.0000000000003407. Epub 2023 Mar 9.
2
Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients with Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.回复：新辅助膀胱内丝裂霉素-C治疗对非肌层浸润性膀胱癌患者经尿道膀胱肿瘤切除术前即刻的临床疗效：一项前瞻性随机II期研究的初步结果
Eur Urol. 2023 Oct;84(4):439-440. doi: 10.1016/j.eururo.2023.03.010. Epub 2023 Mar 25.
3
Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.新辅助膀胱内注射丝裂霉素C治疗对非肌层浸润性膀胱癌患者经尿道膀胱肿瘤切除术前即刻的临床疗效：一项前瞻性、随机II期研究的初步结果
J Urol. 2023 Jan;209(1):131-139. doi: 10.1097/JU.0000000000003002. Epub 2022 Oct 12.
4
Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).UGN-102 ± 经尿道膀胱肿瘤切除术与单纯经尿道膀胱肿瘤切除术治疗低级别中危非肌肉浸润性膀胱癌的随机、对照、3 期试验（ATLAS）。
J Urol. 2023 Oct;210(4):619-629. doi: 10.1097/JU.0000000000003645. Epub 2023 Aug 7.
5
Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial.回复：DaBlaCa - 13研究：丝裂霉素短期强化化疗切除术治疗非肌层浸润性膀胱癌的肿瘤学结局：一项随机对照试验的主要结局
Eur Urol. 2023 Nov;84(5):512-513. doi: 10.1016/j.eururo.2023.05.028. Epub 2023 Jun 1.
6
Safety and Efficacy of Immediate Hyperthermic Intravesical Chemotherapy Following Transurethral Resection of Bladder Tumour (I-HIVEC).经尿道膀胱肿瘤切除术后即刻热灌注膀胱化疗（I-HIVEC）的安全性和有效性
Eur Urol Oncol. 2024 Dec;7(6):1171-1174. doi: 10.1016/j.euo.2024.05.006. Epub 2024 May 27.
7
Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.前瞻性随机临床试验：六氨基己酸光动力辅助经尿道膀胱肿瘤切除术（TURBT）联合单次膀胱内丝裂霉素 C 治疗与传统白光 TURBT 联合丝裂霉素 C 治疗新诊断的非肌层浸润性膀胱癌。
BJU Int. 2013 Dec;112(8):1096-104. doi: 10.1111/bju.12355.
8
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.电渗滴注丝裂霉素即刻经尿道膀胱肿瘤切除术治疗原发性非肌层浸润性膀胱尿路上皮癌患者：一项随机对照试验。
Lancet Oncol. 2011 Sep;12(9):871-9. doi: 10.1016/S1470-2045(11)70190-5. Epub 2011 Aug 8.
9
Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.经尿道治疗非肌肉浸润性膀胱癌：系统评价和荟萃分析。
J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24.
10
Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study.新辅助短期密集膀胱内丝裂霉素 C 方案与每周方案治疗低级别复发性非肌肉浸润性膀胱癌的比较：一项随机 2 期研究的初步结果。
Eur Urol. 2012 Nov;62(5):797-802. doi: 10.1016/j.eururo.2012.05.032. Epub 2012 May 18.

引用本文的文献

1
The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies.癌症干细胞与癌症起源细胞之间的复杂相互作用：对治疗策略的启示。
Front Oncol. 2024 May 10;14:1404628. doi: 10.3389/fonc.2024.1404628. eCollection 2024.